Boyd Watterson Asset Management LLC OH decreased its position in shares of Zimmer Biomet Holdings Inc (NYSE:ZBH) by 20.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,250 shares of the medical equipment provider’s stock after selling 1,092 shares during the quarter. Boyd Watterson Asset Management LLC OH’s holdings in Zimmer Biomet were worth $513,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also recently made changes to their positions in the company. Los Angeles Capital Management & Equity Research Inc. lifted its position in shares of Zimmer Biomet by 99.6% during the second quarter. Los Angeles Capital Management & Equity Research Inc. now owns 9,942 shares of the medical equipment provider’s stock worth $1,277,000 after purchasing an additional 4,960 shares in the last quarter. Schroder Investment Management Group purchased a new stake in shares of Zimmer Biomet during the second quarter worth approximately $4,783,000. CIBC World Markets Inc. purchased a new position in Zimmer Biomet in the second quarter valued at approximately $270,000. Aberdeen Asset Management PLC UK increased its stake in Zimmer Biomet by 6.7% in the second quarter. Aberdeen Asset Management PLC UK now owns 47,505 shares of the medical equipment provider’s stock valued at $6,099,000 after purchasing an additional 2,995 shares during the last quarter. Finally, Financial Counselors Inc. increased its stake in Zimmer Biomet by 1.2% in the second quarter. Financial Counselors Inc. now owns 6,215 shares of the medical equipment provider’s stock valued at $798,000 after purchasing an additional 73 shares during the last quarter. 85.92% of the stock is currently owned by hedge funds and other institutional investors.
Several equities research analysts have recently weighed in on the company. Jefferies Group reissued a “buy” rating and issued a $136.00 price objective on shares of Zimmer Biomet in a report on Friday, November 3rd. Stifel Nicolaus reaffirmed a “hold” rating and set a $120.00 price target on shares of Zimmer Biomet in a report on Friday, November 3rd. SunTrust Banks reaffirmed a “buy” rating and set a $136.00 price target on shares of Zimmer Biomet in a report on Monday, October 2nd. TheStreet cut Zimmer Biomet from a “b-” rating to a “c+” rating in a research report on Friday, November 24th. Finally, Cantor Fitzgerald reiterated an “overweight” rating on shares of Zimmer Biomet in a research report on Friday, January 5th. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $137.42.
Zimmer Biomet Holdings Inc (NYSE ZBH) traded down $1.66 on Thursday, reaching $122.53. The company’s stock had a trading volume of 1,956,600 shares, compared to its average volume of 1,490,986. The company has a quick ratio of 0.78, a current ratio of 1.47 and a debt-to-equity ratio of 0.88. The stock has a market cap of $24,760.00, a PE ratio of 38.17, a price-to-earnings-growth ratio of 1.96 and a beta of 1.15. Zimmer Biomet Holdings Inc has a 52 week low of $108.03 and a 52 week high of $133.49.
Zimmer Biomet (NYSE:ZBH) last released its quarterly earnings data on Wednesday, November 1st. The medical equipment provider reported $1.72 earnings per share for the quarter, missing the consensus estimate of $1.74 by ($0.02). The firm had revenue of $1.82 billion during the quarter, compared to analyst estimates of $1.83 billion. Zimmer Biomet had a net margin of 5.43% and a return on equity of 3.82%. The business’s revenue for the quarter was down .8% on a year-over-year basis. During the same period in the prior year, the firm earned $1.79 earnings per share. equities research analysts predict that Zimmer Biomet Holdings Inc will post 8.03 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, January 29th. Stockholders of record on Friday, December 29th will be paid a $0.24 dividend. This represents a $0.96 annualized dividend and a dividend yield of 0.78%. The ex-dividend date of this dividend is Thursday, December 28th. Zimmer Biomet’s dividend payout ratio is currently 29.91%.
TRADEMARK VIOLATION WARNING: “Boyd Watterson Asset Management LLC OH Sells 1,092 Shares of Zimmer Biomet Holdings Inc (ZBH)” was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The legal version of this report can be read at https://www.dispatchtribunal.com/2018/01/11/boyd-watterson-asset-management-llc-oh-sells-1092-shares-of-zimmer-biomet-holdings-inc-zbh.html.
Zimmer Biomet Profile
Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.
Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings Inc (NYSE:ZBH).
Receive News & Ratings for Zimmer Biomet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet and related companies with MarketBeat.com's FREE daily email newsletter.